Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.

Saved in:
Bibliographic Details
Title: Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B.
Authors: Pipe SW; Departments of Pediatrics and Pathology, University of Michigan, Ann Arbor., Miesbach W; University Hospital Frankfurt, Frankfurt, Germany., Recht M; Yale School of Medicine, New Haven, CT.; National Bleeding Disorders Foundation, New York., Leebeek FWG; Department of Hematology, Erasmus University Medical Center (UMC) Rotterdam, Rotterdam, the Netherlands., Key NS; Department of Medicine and Blood Research Center, University of North Carolina, Chapel Hill., Castaman G; Center for Bleeding Disorders and Coagulation, Department of Heart, Lungs, and Vessels, Careggi University Hospital, Florence, Italy., Lattimore S; Oregon Heath and Science University, Portland., Coppens M; Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam.; Amsterdam Cardiovascular Sciences, Pulmonary Hypertension and Critical Care, Amsterdam., Le Quellec S; CSL Behring, King of Prussia, PA., Mahajan V; CSL Behring, King of Prussia, PA., Gill S; CSL Behring, King of Prussia, PA., Drelich D; CSL Behring, King of Prussia, PA., Monahan PE; CSL Behring, King of Prussia, PA.
Corporate Authors: HOPE-B Study Group Investigators
Source: The New England journal of medicine [N Engl J Med] 2026 Jan 29; Vol. 394 (5), pp. 463-474. Date of Electronic Publication: 2025 Dec 07.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMoa2514332